1、 LIU Y Y,CHEN M K,CAO Z,et al.Differential diagnosis of intestinal tuberculosis from Crohn's disease and primary intestinal lymphoma in China[J]. Saudi J Gastroenterol,2014,20(4):241-247. LIU Y Y,CHEN M K,CAO Z,et al.Differential diagnosis of intestinal tuberculosis from Crohn's disease and primary intestinal lymphoma in China[J]. Saudi J Gastroenterol,2014,20(4):241-247.
2、 HUANG X,LIAO W D,YU C,et al.Differences in clinical features of Crohn's disease and intestinal tuberculosis[J]. World J Gastroenterol,2015,21(12):3650-3656. HUANG X,LIAO W D,YU C,et al.Differences in clinical features of Crohn's disease and intestinal tuberculosis[J]. World J Gastroenterol,2015,21(12):3650-3656.
3、 SHARMA R,MADHUSUDHAN K S,AHUJA V.Intestinal tuberculosis versus crohn's disease:Clinical and radiological recommendations[J]. Indian J Radiol Imaging,2016,26(2):161-172. SHARMA R,MADHUSUDHAN K S,AHUJA V.Intestinal tuberculosis versus crohn's disease:Clinical and radiological recommendations[J]. Indian J Radiol Imaging,2016,26(2):161-172.
4、 BURGER M,SCHMIDT C,TEICH N,et al.Medical therapy of active ulcerative colitis[J]. Viszeralmedizin,2015,31(4):236-245. BURGER M,SCHMIDT C,TEICH N,et al.Medical therapy of active ulcerative colitis[J]. Viszeralmedizin,2015,31(4):236-245.
5、 BRESSENOT A M,RIDDELL R H,BOULAGNON-ROMBI C,et al.Review article:the histological assessment of disease activity in ulcerative colitis[J]. Aliment Pharmacol Ther ,2015,42(8):957-967. BRESSENOT A M,RIDDELL R H,BOULAGNON-ROMBI C,et al.Review article:the histological assessment of disease activity in ulcerative colitis[J]. Aliment Pharmacol Ther ,2015,42(8):957-967.
6、 FERNANDO GOMOLLóN,AXEL DIGNASS,VITO ANNESE,et al.3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016:Part 1:diagnosis and medical management[J]. J Crohn's Colitis,2015,4(1):7. FERNANDO GOMOLLóN,AXEL DIGNASS,VITO ANNESE,et al.3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016:Part 1:diagnosis and medical management[J]. J Crohn's Colitis,2015,4(1):7.
7、 MAGRO F,LANGNER C,DRIESSEN A,et al.European consensus on the histopathology of inflammatory bowel disease[J]. J Crohns Colitis,2013,7(10):827-851. MAGRO F,LANGNER C,DRIESSEN A,et al.European consensus on the histopathology of inflammatory bowel disease[J]. J Crohns Colitis,2013,7(10):827-851.
8、 VAVRICKA SR,SPIGAGLIA SM,ROGLER G,et al.Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease[J]. Inflamm Bowel Dis,2012,18(3):496-505. VAVRICKA SR,SPIGAGLIA SM,ROGLER G,et al.Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease[J]. Inflamm Bowel Dis,2012,18(3):496-505.
9、 ARATARI A,PAPI C,GALLETTI B,et al.Seasonal variations in onset of symptoms in Crohn's disease[J]. Dig Liver Dis,2006,38(5):319-323. ARATARI A,PAPI C,GALLETTI B,et al.Seasonal variations in onset of symptoms in Crohn's disease[J]. Dig Liver Dis,2006,38(5):319-323.
10、 Xiong H F,Wang B,Zhao Z H,et al. Tonsillectomy and inflammatory bowel disease:a meta-analysis[J]. Colorectal Dis,2016,18(5):O145- O 153. Xiong H F,Wang B,Zhao Z H,et al. Tonsillectomy and inflammatory bowel disease:a meta-analysis[J]. Colorectal Dis,2016,18(5):O145- O 153.
11、 ANANTHAKRISHNAN A N,CHENG A,CAGAN A,et al.Mode of childbirth and long-term outcomes in women with inflammatory bowel diseases[J]. Dig Dis Sci,2015,60(2):471-477. ANANTHAKRISHNAN A N,CHENG A,CAGAN A,et al.Mode of childbirth and long-term outcomes in women with inflammatory bowel diseases[J]. Dig Dis Sci,2015,60(2):471-477.
12、 MARTIN J,KANE SV,FEAGINS L A.Fertility and contraception in women with inflammatory bowel disease[J]. Gastroenterol Hepatol (N Y),2016,12(2):101-109. MARTIN J,KANE SV,FEAGINS L A.Fertility and contraception in women with inflammatory bowel disease[J]. Gastroenterol Hepatol (N Y),2016,12(2):101-109.
13、 ZULLOW S,JAMBAULIKAR G,RUSTGI A,et al.Risk factors for vitamin D deficiency and impact of repletion in a tertiary care inflammatory bowel disease population[J]. Gastroenterol , 2012 , 142(5) :1-7. ZULLOW S,JAMBAULIKAR G,RUSTGI A,et al.Risk factors for vitamin D deficiency and impact of repletion in a tertiary care inflammatory bowel disease population[J]. Gastroenterol , 2012 , 142(5) :1-7.
14、 SONG EM,SEO M,Hwang S W,et al.Assessment of factors associated with smoking cessation at diagnosis or during follow-up of Crohn's disease[J]. J Gastroenterol Hepatol ,2018,33(1):180-186. SONG EM,SEO M,Hwang S W,et al.Assessment of factors associated with smoking cessation at diagnosis or during follow-up of Crohn's disease[J]. J Gastroenterol Hepatol ,2018,33(1):180-186.
15、 MAASER CHRISTIAN,LANGHOLZ EBBE,B GORDON HANNAH,et al. European Crohn’s and colitis organisation topical review on environmental factors in IBD[J]. J Crohn's Colitis,2016,11(8):905-920. MAASER CHRISTIAN,LANGHOLZ EBBE,B GORDON HANNAH,et al. European Crohn’s and colitis organisation topical review on environmental factors in IBD[J]. J Crohn's Colitis,2016,11(8):905-920.
16、 SHEN Z,ZHU C,QUAN Y,et al.Update on intestinal microbiota in Crohn's disease 2017:mechanisms,clinical application,adverse reactions,and outlook[J]. J Gastroenterol Hepatol,2017,32(11):1804-1812. SHEN Z,ZHU C,QUAN Y,et al.Update on intestinal microbiota in Crohn's disease 2017:mechanisms,clinical application,adverse reactions,and outlook[J]. J Gastroenterol Hepatol,2017,32(11):1804-1812.
17、 MOSLI M,BESHIR M A L,AL-JUDAIBI B,et al. Advances in the diagnosis and management of inflammatory bowel disease:challenges and uncertainties[J]. Saudi J Gastroenterol ,2014,20(2):81-101. MOSLI M,BESHIR M A L,AL-JUDAIBI B,et al. Advances in the diagnosis and management of inflammatory bowel disease:challenges and uncertainties[J]. Saudi J Gastroenterol ,2014,20(2):81-101.
18、 SANDBORN W,COLOMBEL J F,D'HAENS G,et al. The Crohn's disease-ulcerative colitis clinical appraisal update:emerging trends in clinical practice[J]. Clin Gastroenterol Hepatol,2016,14(9):e121-122. SANDBORN W,COLOMBEL J F,D'HAENS G,et al. The Crohn's disease-ulcerative colitis clinical appraisal update:emerging trends in clinical practice[J]. Clin Gastroenterol Hepatol,2016,14(9):e121-122.
19、 SOBRADO C W,LEAL R F,SOBRADO L F.THERAPIES FOR CROHN'S DISEASE:A clinical update[J]. Arq Gastroenterol ,2016,53(3):206-211. SOBRADO C W,LEAL R F,SOBRADO L F.THERAPIES FOR CROHN'S DISEASE:A clinical update[J]. Arq Gastroenterol ,2016,53(3):206-211.
20、 ZORZI F,CALABRESE E,MONTELEONE G.Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease[J]. Clin Sci (Lond) ,2015,129(12):1107-1113. ZORZI F,CALABRESE E,MONTELEONE G.Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease[J]. Clin Sci (Lond) ,2015,129(12):1107-1113.
